Florida College Newswire (Page 3)

Florida College Newswire (Page 3)

Comprehensive Real-Time News Feed for Florida College. (Page 3)

Results 41 - 60 of 1,834 in Florida College

  1. To floss or not? Canadian and U.S. dentists continue to urge flossingRead the original story w/Photo

    Wednesday Aug 3 | GlobalNews

    ... professor and chairman of the department of community dentistry and behavioural science at the University Of Florida College of Dentistry. "It comes as no surprise to most of us in the dental public health community," Tomar told Global News. "We ...

    Comment?

  2. FibroGen to Report Second Quarter 2016 Financial Results on August 8, 2016Read the original story

    Tuesday Aug 2 | P&T Community

    ... www.fibrogen.com . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  3. USF-led research group to study Gulf of Mexico oil spillsRead the original story w/Photo

    Tuesday Aug 2 | Tampa Bay Newspapers

    Researchers from the University of South Florida College of Marine Science, along with colleagues representing institutions across the country and internationally, are set to embark on a 40-day research cruise through the Gulf Mexico to gather key data that will provide a more complete understanding of the destructive effects from two significant oil spills. The USF-led research group will study the seas, coastlines and reefs impacted by the 2010 Deepwater Horizon and 1979 Ixtoc oil spills, the two largest submarine blowouts in history.

    Comment?

  4. Caladrius Biosciences to Host 2016 Second Quarter Financial Results...Read the original story

    Tuesday Aug 2 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  5. ChromaDex to Report Second Quarter 2016 Financial Results on Thursday, August 11, 2016Read the original story

    Tuesday Aug 2 | P&T Community

    ... the date hereof. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  6. INC Research Announces 2016 Analyst and Investor DayRead the original story

    Monday Aug 1 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  7. Anavex Confirms Data from Phase 2a Study of ANAVEX 2-73 in...Read the original story

    Jul 29, 2016 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  8. HTG Molecular Diagnostics to Hold 2016 Second Quarter Financial...Read the original story

    Jul 28, 2016 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  9. Agios to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016Read the original story

    Jul 28, 2016 | P&T Community

    ... at www.agios.com . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  10. North Florida Community College named "2016 Great College to Work...Read the original story w/Photo

    Jul 28, 2016 | Greene Publishing, Inc.

    ... health and wellness programs, an outstanding benefits package, and professional collaboration within the Florida College System and beyond." The Chronicle's Great Colleges to Work For survey is one of the largest and most respected ...

    Comment?

  11. Fibrocell to Host Conference Call and Webcast on Thursday, August 4,...Read the original story

    Jul 28, 2016 | P&T Community

    ... at @Fibrocell . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  12. Cara Therapeutics to Announce Second Quarter 2016 Financial Results on August 4, 2016Read the original story

    Jul 28, 2016 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  13. MacroGenics Announces Date of Second Quarter 2016 Financial Results Conference CallRead the original story

    Jul 27, 2016 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  14. CytomX Therapeutics to Announce Second Quarter 2016 Financial Results and Provide Mid-Year UpdateRead the original story

    Jul 27, 2016 | P&T Community

    ... 646-378-2973 Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very ...

    Comment?

  15. Guest column: Changing parties to vote for CoferRead the original story w/Photo

    Jul 27, 2016 | The Florida Times-Union

    ... 21 years, and he was my supervisor when I was an assistant public defender straight out of the University of Florida College of Law. He was a mentor and guide to me on just how to zealously defend my clients who were charged with criminal defenses. ...

    Comment?

  16. Task Force Issues Recommendation Statement on Skin Cancer ScreeningRead the original story

    Jul 27, 2016 | P&T Community

    ... in adults. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very ...

    Comment?

  17. Geron Announces Conference Call to Discuss Second Quarter 2016 Financial ResultsRead the original story

    Jul 27, 2016 | P&T Community

    ... www.geron.com . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was ...

    Comment?

  18. Conatus Pharmaceuticals to Report Second Quarter 2016 Financial ResultsRead the original story

    Jul 27, 2016 | P&T Community

    ... Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  19. Loxo Oncology to Announce Second Quarter 2016 Financial ResultsRead the original story

    Jul 27, 2016 | P&T Community

    ... . Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug was very effective ...

    Comment?

  20. VBL Therapeutics to Report Second Quarter 2016 Financial Results on August 15Read the original story

    Jul 26, 2016 | P&T Community

    ... Orphan designations. Robert A. Hromas, MD, Chair of the Department of Internal Medicine at the University of Florida College of Medicine, describes "very exciting" findings about venetoclax in treating chronic lymphocytic leukemia (CLL). The drug ...

    Comment?